Skip to content

Penumbra PEN Gross Profit

Gross Profit at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
Stryker logo
StrykerSYK
$3.81B+1.8%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Calculated from Penumbra’s reported figures.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's gross profit?
Penumbra (PEN) reported gross profit of $253.41M in Q1 2026.
How has Penumbra's gross profit changed year-over-year?
Penumbra's gross profit increased by 17.4% year-over-year, from $215.88M to $253.41M.
What is the long-term trend for Penumbra's gross profit?
Over 4 years (2021 to 2025), Penumbra's gross profit has grown at a 18.7% compound annual growth rate (CAGR), from $475.38M to $942.44M.
What does gross profit mean?
The profit remaining after subtracting the direct costs of producing goods from total sales.
How do you interpret gross profit?
Higher gross profit indicates strong pricing power or efficient production, whereas declining gross profit may indicate pricing pressure or rising input costs.
How does gross profit compare across companies?
A fundamental profitability metric used to compare operational efficiency across the medical device sector.